Gina P Mejía-Abril (Gina Mejía-Abril, Gina Mejía)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Venues

Pharmaceutics

Journal of personalized medicine

NPJ vaccines

Pharmaceuticals (Basel, Switzerland)

Hospital Universitario de La Princesa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario de La Princesa Sep 01 2015

Spain

Médica especialista en Farmacología Clínica :: Farmacología Clínica

Publications

Pedro Martínez-Fleta, Esther F Vicente-Rabaneda, Ana Triguero-Martínez, Emilia Roy-Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, Patricia Quiroga-Colina, Ana Romero-Robles, Nuria Montes, Noelia García-Castañeda, Gina P Mejía-Abril, Jesús A García-Vadillo, Irene Llorente-Cubas, José R Villagrasa, José M Serra López-Matencio, Julio Ancochea, Ana Urzainqui, Laura Esparcia-Pinedo, Arantzazu Alfranca, Hortensia de la Fuente, Rosario García-Vicuña, Francisco Sánchez-Madrid, Isidoro González-Alvaro, Santos Castañeda
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis. NPJ vaccines 9 (1) (2024)
Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias, Samuel Martín-Vílchez, Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Manuel Román, Sergio Luquero-Bueno, Dolores Ochoa, Francisco Abad-Santos
Genetic Variation in CYP2D6 , UGT1A4 , SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron. Pharmaceutics 16 (8) (2024)
Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias, Samuel Martín-Vílchez, Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Manuel Román, Sergio Luquero-Bueno, Dolores Ochoa, Francisco Abad-Santos
Genetic Variation in CYP2D6 , UGT1A4 , SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron. Pharmaceutics 16 (8) (2024)
Pedro Martínez-Fleta, Esther F Vicente-Rabaneda, Ana Triguero-Martínez, Emilia Roy-Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, Patricia Quiroga-Colina, Ana Romero-Robles, Nuria Montes, Noelia García-Castañeda, Gina P Mejía-Abril, Jesús A García-Vadillo, Irene Llorente-Cubas, José R Villagrasa, José M Serra López-Matencio, Julio Ancochea, Ana Urzainqui, Laura Esparcia-Pinedo, Arantzazu Alfranca, Hortensia de la Fuente, Rosario García-Vicuña, Francisco Sánchez-Madrid, Isidoro González-Alvaro, Santos Castañeda
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis. NPJ vaccines 9 (1) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa
Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals (Basel, Switzerland) 17 (1) (2024)
Pedro Martínez-Fleta, Esther F Vicente-Rabaneda, Ana Triguero-Martínez, Emilia Roy-Vallejo, Miren Uriarte-Ecenarro, Francisco Gutiérrez-Rodríguez, Patricia Quiroga-Colina, Ana Romero-Robles, Nuria Montes, Noelia García-Castañeda, Gina P Mejía-Abril, Jesús A García-Vadillo, Irene Llorente-Cubas, José R Villagrasa, José M Serra López-Matencio, Julio Ancochea, Ana Urzainqui, Laura Esparcia-Pinedo, Arantzazu Alfranca, Hortensia de la Fuente, Rosario García-Vicuña, Francisco Sánchez-Madrid, Isidoro González-Alvaro, Santos Castañeda
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patients with rheumatoid arthritis or psoriatic arthritis. NPJ vaccines 9 (1) (2024)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Marcos Navares-Gómez, Houwaida Abbes, Gonzalo Villapalos-García, Alejandro de Miguel, Eva González-Iglesias, Andrea Rodríguez-Lopez, Gina P Mejía-Abril, Samuel Martín-Vilchez, Sergio Luquero-Bueno, Manuel Román, Francisco Abad-Santos
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide. International journal of molecular sciences 24 (20) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Paula Soria-Chacartegui, Pablo Zubiaur, Dolores Ochoa, Gonzalo Villapalos-García, Manuel Román, Miriam Matas, Laura Figueiredo-Tor, Gina P Mejía-Abril, Sofía Calleja, Alejandro de Miguel, Marcos Navares-Gómez, Samuel Martín-Vilchez, Francisco Abad-Santos
Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety. Pharmaceutics 15 (2) (2023)
Gonzalo Villapalos-García, Pablo Zubiaur, Cristina Marián-Revilla, Paula Soria-Chacartegui, Marcos Navares-Gómez, Gina P Mejía-Abril, Andrea Rodríguez-Lopez, Eva González-Iglesias, Samuel Martín-Vílchez, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride. Journal of personalized medicine 13 (11) (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Miriam Saiz-Rodriguez, Dolores Ochoa, Pablo Zubiaur, Marcos Navares-Gómez, Manuel Román, Paola Camargo-Mamani, Sergio Luquero-Bueno, Gonzalo Villapalos-García, Raquel Alcaraz, Gina P Mejía-Abril, Estefanía Santos-Mazo, Francisco Abad-Santos
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 13 (3) (2023)
Diana María Campodónico, Pablo Zubiaur, Paula Soria-Chacartegui, Ana Casajús, Gonzalo Villapalos-García, Marcos Navares-Gómez, Antía Gómez-Fernández, Raúl Parra-Garcés, Gina P Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride. Clinical and translational science 15 (11) (2022)
Pablo Zubiaur, David Nicolás Prósper-Cuesta, Jesús Novalbos, Gina P Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Francisco Abad-Santos
Patients' Perceptions of Pharmacogenetic Testing and Access to Their Results: State of the Art in Spain and Systematic Review. Journal of personalized medicine 12 (2) (2022)
Pablo Zubiaur, Miriam Matas, Samuel Martín-Vílchez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Laura Figueiredo-Tor, Sofía Calleja, Marcos Navares-Gómez, Alejandro de Miguel, Jesús Novalbos, Gina P Mejía-Abril, Sergio Luquero-Bueno, Manuel Román, Dolores Ochoa, Francisco Abad-Santos
Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline. Pharmaceutics 14 (10) (2022)
Pablo Zubiaur, Gina P Mejía-Abril, Marcos Navares-Gómez, Gonzalo Villapalos-García, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Dolores Ochoa, Francisco Abad-Santos
PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics. Journal of clinical medicine 10 (17) (2021)
Paula Soria-Chacartegui, Gonzalo Villapalos-García, Luis A López-Fernández, Marcos Navares-Gómez, Gina P Mejía-Abril, Francisco Abad-Santos, Pablo Zubiaur
Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase ( DPYD ) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study. Pharmaceutics 13 (12) (2021)
Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Manuel Román, Gina P Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics 13 (10) (2021)
Pablo Zubiaur, Lisa A Kneller, Dolores Ochoa, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Alberto M Borobia, Dora Koller, Irene García García, Marcos Navares-Gómez, Georg Hempel, Francisco Abad-Santos
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 60 (2) (2021)
Dora Koller, Susana Almenara, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Aneta Wojnicz, Samuel Martín, Daniel Romero-Palacián, Marcos Navares-Gómez, Francisco Abad-Santos
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial. Human psychopharmacology 36 (1) (2020)
Miriam Saiz-Rodriguez, Susana Almenara, Marcos Navares-Gómez, Dolores Ochoa, Manuel Román, Pablo Zubiaur, Dora Koller, María Santos, Gina P Mejía-Abril, Alberto M Borobia, Cristina Rodríguez-Antona, Francisco Abad-Santos
Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates. Biomedicines 8 (4) (2020)

Gina P Mejía-Abril.css-eqlu8i{font-size:small;padding-left:4px;} (Gina Mejía-Abril, Gina Mejía)

Publication Activity (10 Years)

Top Topics

Top Venues

Gina P Mejía-Abril (Gina Mejía-Abril, Gina Mejía)